Natural antibodies produced in vaccinated patients and COVID-19 convalescents recognize and hydrolyze oligopeptides corresponding to the S-protein of SARS-CoV …

AM Timofeeva, SE Sedykh, TA Sedykh, GA Nevinsky - Vaccines, 2023 - mdpi.com
The S-protein is the major antigen of the SARS-CoV-2 virus, against which protective
antibodies are generated. The S-protein gene was used in adenoviral vectors and mRNA …

Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity against Burkholderia cenocepacia infection in mice

WE Gawad, YI Nagy, TM Samir, AMI Mansour… - npj Vaccines, 2025 - nature.com
Burkholderia cenocepacia causes life-threatening infections in immunocompromised
patients. Treatment is challenging due to intrinsic antibiotic multiresistance, so vaccination …

Mass spectrometry-based immunopeptidomics and computational vaccinology strategies for the identification of universal Shigella immunogenic candidates

NRM Shabani, CMKH Ismail, AA Anthony… - Computers in Biology …, 2022 - Elsevier
Shigella is a Gram-negative bacteria that cause shigellosis. Treatment with antibiotics
cannot be sustained to control the bacterial infection due to the risk of antibiotic resistance …

Insights into structural vaccinology harnessed for universal coronavirus vaccine development

CP Lim, CH Leow, HT Lim, BH Kok… - Clinical and …, 2024 - pmc.ncbi.nlm.nih.gov
Structural vaccinology is pivotal in expediting vaccine design through high-throughput
screening of immunogenic antigens. Leveraging the structural and functional characteristics …

Tools and platform for allergenicity prediction

SK Mishra, JJ Georrge - Reverse Vaccinology, 2024 - Elsevier
The immune system's role is to keep our body free from the viral pathogen, not to trigger any
diseases. Hence, it makes sense to characterize all types of modern allergenicity, that is, to …

Cyclic di AMP phosphodiesterase nanovaccine elicits protective immunity

WE Gawad, YI Nagy, TM Samir, AMI Mansour… - search.proquest.com
Burkholderia cenocepacia causes life-threatening infections in immunocompromised
patients. Treatment is challenging due to intrinsic antibiotic multiresistance, so vaccination …